Suppr超能文献

老年女性腹主动脉钙化、心肌肌钙蛋白 I 与动脉粥样硬化性血管疾病死亡率。

Abdominal aortic calcification, cardiac troponin I and atherosclerotic vascular disease mortality in older women.

机构信息

Medical School, The University of Western Australia, Perth, Western Australia, Australia.

Fiona Stanley Hospital, Murdoch, Western Australia, Australia.

出版信息

Heart. 2022 Jul 27;108(16):1274-1280. doi: 10.1136/heartjnl-2021-319879.

Abstract

OBJECTIVE

Examine if two inexpensive measures of atherosclerotic vascular diseases (ASVD), abdominal aortic calcification (AAC) and high-sensitivity cardiac troponin I (hs-cTnI) provide complementary information for 10-year ASVD mortality and all-cause mortality risk in older women.

METHODS

908 community-dwelling women without prevalent ASVD (≥75 years) were followed-up between 2003 and 2013. AAC and plasma hs-cTnI measures were obtained in 2003. AAC was assessed on lateral spine images using a semiquantitative method (AAC24). Linked health records were used for mortality outcomes.

RESULTS

Mean±SD age was 79.9±2.6 years. 276 (30.4%) women died during follow-up, including 138 (15.2%) ASVD-related deaths. AAC24 and hs-cTnI were independently associated with ASVD and all-cause mortality (p<0.001). The cohort was dichotomised into four groups: (1) low AAC24 (AAC24: 0 or 1) and <median hs-cTnI (n=163, referent), (2) moderate-extensive AAC24 (AAC24:>1) and <median hs-cTnI (n=280), (3) low AAC24 and ≥median hs-cTnI (n=148) and (4) moderate-extensive AAC24 and ≥median hs-cTnI (n=317). Compared with the referent group, a stepwise increase in relative hazard (HR (95% CI)) for ASVD mortality was seen at 2.39 (1.05 to 5.46), 3.18 (1.35 to 7.79) and 5.38 (2.44 to 11.85), respectively. A similar associations were observed for all-cause mortality, at 1.58 (0.99-2.52), 2.38 (1.46-3.89) and 3.02 (1.93-4.72), respectively (all p<0.05).

CONCLUSION

Higher AAC and elevated hs-cTnI were associated with higher risk of ASVD mortality and all-cause mortality, independent of each other. Stratifying by moderate to extensive AAC and elevated hs-cTnI identified women at very high risk. Further studies investigating whether combining factors may improve risk prediction are needed.

TRIAL REGISTRATION NUMBER

ACTRN12617000640303.

摘要

目的

探讨两种廉价的动脉粥样硬化性血管疾病(ASVD)指标,即腹主动脉钙化(AAC)和高敏心肌肌钙蛋白 I(hs-cTnI),是否能为老年女性 10 年 ASVD 死亡率和全因死亡率风险提供补充信息。

方法

对 908 名无明显 ASVD(≥75 岁)的社区居民进行随访,随访时间为 2003 年至 2013 年。2003 年获取 AAC 和血浆 hs-cTnI 测量值。使用半定量方法(AAC24)在侧位脊柱图像上评估 AAC。链接的健康记录用于死亡结局。

结果

平均年龄为 79.9±2.6 岁。94 名女性(10.4%)在随访期间死亡,其中 138 名(15.2%)与 ASVD 相关。AAC24 和 hs-cTnI 与 ASVD 和全因死亡率均独立相关(p<0.001)。将队列分为四组:(1)低 AAC24(AAC24:0 或 1)和<中位数 hs-cTnI(n=163,参考组),(2)中-高度 AAC24(AAC24:>1)和<中位数 hs-cTnI(n=280),(3)低 AAC24 和≥中位数 hs-cTnI(n=148),(4)中-高度 AAC24 和≥中位数 hs-cTnI(n=317)。与参考组相比,ASVD 死亡率的相对危险度(HR(95%CI))分别为 2.39(1.05-5.46)、3.18(1.35-7.79)和 5.38(2.44-11.85),逐渐增加。全因死亡率也观察到类似的关联,分别为 1.58(0.99-2.52)、2.38(1.46-3.89)和 3.02(1.93-4.72)(均 p<0.05)。

结论

较高的 AAC 和升高的 hs-cTnI 与 ASVD 死亡率和全因死亡率风险增加相关,且彼此独立。按中度至高度 AAC 和升高的 hs-cTnI 分层可确定极高风险的女性。需要进一步研究联合因素是否可以改善风险预测。

试验注册号

ACTRN12617000640303。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验